Related Experiment Video

Updated: May 15, 2026

Whole-Body Nanoparticle Aerosol Inhalation Exposures
10:11

Whole-Body Nanoparticle Aerosol Inhalation Exposures

Published on: May 7, 2013

Handling worker and third-party exposures to nanotherapeutics during clinical trials

Gurumurthy Ramachandran1, John Howard, Andrew Maynard

  • 1Division of Environmental Health Sciences, School of Public Health, University of Minnesota in Minneapolis, MN, USA.

The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics
|January 8, 2013
PubMed

More Related Videos

A System to Create Stable Nanoparticle Aerosols from Nanopowders12:59

A System to Create Stable Nanoparticle Aerosols from Nanopowders

Published on: July 26, 2016

Testing of Nanoparticle Release from a Composite Containing Nanomaterial Using a Chamber System04:55

Testing of Nanoparticle Release from a Composite Containing Nanomaterial Using a Chamber System

Published on: November 22, 2016

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...